Astellas Loses Bid to Block Myrbetriq Copies During Patent Suit – Bloomberg Law News

A federal judge rejected Astellas Pharma Inc.’s requests to block Lupin’s and Zydus’ copies of the overactive-bladder treatment Myrbetriq during a …